Diamines & Chemicals Ltd Receives Trading Approval for 269,402 Equity Shares Following Preferential Warrant Conversion
Diamines & Chemicals Ltd has received trading approval from both the National Stock Exchange of India Limited (NSE) and BSE Limited. The approval pertains to the allotment of 2,69,402 equity shares of Rs. 10/- each, which were issued following the conversion of warrants on a preferential basis.The company confirmed that the newly allotted equity shares are listed and admitted to dealings on both exchanges starting from June 12, 2026. This move marks a significant addition to the company’s capital structure.
Upon securing the necessary trading approvals, the Listed Capital of Diamines & Chemicals Ltd will reach Rs. 10,05,33,920, corresponding to 1,00,53,392 fully paid equity shares of Rs. 10/- each.
The details pertaining to this tranche of the preferential issuance are as follows:
| Particulars | Details |
|---|---|
| Number of Shares Allotted | 269,402 |
| Face Value Per Share | Rs. 10/- each |
| Distinctive Numbers Range | 9783991 to 10053392 |
| Lock-in Period Expiry Date | 14 December 2026 |
The allotment of these securities represents a portion of the overall preferential issue, which also includes shares allotted under different ranges with varied lock-in periods.
Data regarding the share allocations and respective lock-in commitments for this tranche is presented below:
| No. of Shares | Distinctive Numbers Range | Date up to which Lock-in |
|---|---|---|
| 269,402 | From 9783991 To 10053392 | 14 December 2026 |
DIAMINESQ Stock Price Movement
Shares of Diamines & Chemicals Limited are gaining modestly as of 12:30 PM today, reaching ₹244.99 after climbing by ₹0.24 in live trading. The equity has traded a volume of 1,038 shares so far during the session, showing steady momentum in the specialty chemicals sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.